Source link : https://www.newshealth.biz/health-news/once-rejected-drug-now-fda-approved-for-ckd-related-anemia/
The FDA approved vadadustat (Vafseo) for chronic kidney disease (CKD)-related anemia in adults who have been on dialysis for at least 3 months, developer Akebia Therapeutics announced on Wednesday. “Patients receiving maintenance dialysis would benefit from additional therapeutic options that can effectively increase and maintain hemoglobin concentrations within guideline-recommended target ranges,” said co-chair of the […]
Author : News Health
Publish date : 2024-03-28 14:27:05
Copyright for syndicated content belongs to the linked Source.
Categories